Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

p53 might be useful to distinguish Langerhans cell hyperplasia from Langerhans cell histiocytosis

March 10, 2016

Acetazolamide counters effects of Klotho hypomorphism on aging

Jan. 20, 2016

Eagle Pharmaceuticals reports phase II results for dantrolene in exertional heat stroke

Dec. 22, 2015

Tocopherol-conjugated DNA/RNA heteroduplex oligonucleotides enhance brain and liver targeting

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...